Cargando…

Metabolite Profiling of Osteoporosis and Atherosclerosis in Postmenopausal Women: A Cross-Sectional Study

PURPOSE: Atherosclerosis (AS) and osteoporosis (OP) are common causes of morbidity and mortality in postmenopausal women and are connected via an unknown mechanistic link. Metabolite profiling of blood samples may allow the identification of new biomarkers and pathways for this enigmatic association...

Descripción completa

Detalles Bibliográficos
Autores principales: Värri, Miika, Niskanen, Leo, Tuomainen, Tomi-Pekka, Honkanen, Risto, Kröger, Heikki, Tuppurainen, Marjo T
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7719314/
https://www.ncbi.nlm.nih.gov/pubmed/33293818
http://dx.doi.org/10.2147/VHRM.S279028
_version_ 1783619653906464768
author Värri, Miika
Niskanen, Leo
Tuomainen, Tomi-Pekka
Honkanen, Risto
Kröger, Heikki
Tuppurainen, Marjo T
author_facet Värri, Miika
Niskanen, Leo
Tuomainen, Tomi-Pekka
Honkanen, Risto
Kröger, Heikki
Tuppurainen, Marjo T
author_sort Värri, Miika
collection PubMed
description PURPOSE: Atherosclerosis (AS) and osteoporosis (OP) are common causes of morbidity and mortality in postmenopausal women and are connected via an unknown mechanistic link. Metabolite profiling of blood samples may allow the identification of new biomarkers and pathways for this enigmatic association. PATIENTS AND METHODS: We studied the difference in 148 metabolite levels from serum samples in postmenopausal women with AS and OP compared with those in healthy participants in this cross-sectional study. Quantitative AS was assessed by carotid artery intima-media thickness (cIMT) and carotid artery calcifications (CACs) by ultrasound, as well as OP by femoral neck (FN) bone mineral density (BMD) and 148 metabolic measures with high-throughput proton ((1)H) nuclear magnetic resonance (NMR) in serum samples from 280 postmenopausal (PM) women. Subjects were a randomly selected subsample from the population-based Kuopio Osteoporosis Risk Factor and Prevention (OSTPRE) study. The final study population included the following groups: OP with CAC (n=16, group I), non-OP with no CAC (n=59, group II), high cIMT tertile with OP (n=11, group III) and low cIMT tertile without OP (n=48, group IV). RESULTS: There were differences in several metabolite levels between groups I and II. The acetate level was lower in group I compared to that in group II (group I mean ± SD: 0.033 ± 0.0070; group II: 0.041 ± 0.014, CI95%: 0.018‒0.15, p=0.014). The result was similar with diacylglycerol (p=0.002), leucine (p=0.031), valine (p=0.022) and several very low-density lipoprotein (VLDL) metabolite levels, which were lower in group I compared to those in group II. However, no associations were found in adjusted analyses with total body (TB) fat mass (FM), age and statin use (p>0.05). CONCLUSION: Our novel study found differences in the metabolite profiling of altered amino acid and lipoprotein metabolism in participants with OP and AS compared with those in healthy women. The causative mechanisms remain unknown and further studies are needed.
format Online
Article
Text
id pubmed-7719314
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-77193142020-12-07 Metabolite Profiling of Osteoporosis and Atherosclerosis in Postmenopausal Women: A Cross-Sectional Study Värri, Miika Niskanen, Leo Tuomainen, Tomi-Pekka Honkanen, Risto Kröger, Heikki Tuppurainen, Marjo T Vasc Health Risk Manag Original Research PURPOSE: Atherosclerosis (AS) and osteoporosis (OP) are common causes of morbidity and mortality in postmenopausal women and are connected via an unknown mechanistic link. Metabolite profiling of blood samples may allow the identification of new biomarkers and pathways for this enigmatic association. PATIENTS AND METHODS: We studied the difference in 148 metabolite levels from serum samples in postmenopausal women with AS and OP compared with those in healthy participants in this cross-sectional study. Quantitative AS was assessed by carotid artery intima-media thickness (cIMT) and carotid artery calcifications (CACs) by ultrasound, as well as OP by femoral neck (FN) bone mineral density (BMD) and 148 metabolic measures with high-throughput proton ((1)H) nuclear magnetic resonance (NMR) in serum samples from 280 postmenopausal (PM) women. Subjects were a randomly selected subsample from the population-based Kuopio Osteoporosis Risk Factor and Prevention (OSTPRE) study. The final study population included the following groups: OP with CAC (n=16, group I), non-OP with no CAC (n=59, group II), high cIMT tertile with OP (n=11, group III) and low cIMT tertile without OP (n=48, group IV). RESULTS: There were differences in several metabolite levels between groups I and II. The acetate level was lower in group I compared to that in group II (group I mean ± SD: 0.033 ± 0.0070; group II: 0.041 ± 0.014, CI95%: 0.018‒0.15, p=0.014). The result was similar with diacylglycerol (p=0.002), leucine (p=0.031), valine (p=0.022) and several very low-density lipoprotein (VLDL) metabolite levels, which were lower in group I compared to those in group II. However, no associations were found in adjusted analyses with total body (TB) fat mass (FM), age and statin use (p>0.05). CONCLUSION: Our novel study found differences in the metabolite profiling of altered amino acid and lipoprotein metabolism in participants with OP and AS compared with those in healthy women. The causative mechanisms remain unknown and further studies are needed. Dove 2020-12-02 /pmc/articles/PMC7719314/ /pubmed/33293818 http://dx.doi.org/10.2147/VHRM.S279028 Text en © 2020 Värri et al. http://creativecommons.org/licenses/by-nc/3.0/ This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Värri, Miika
Niskanen, Leo
Tuomainen, Tomi-Pekka
Honkanen, Risto
Kröger, Heikki
Tuppurainen, Marjo T
Metabolite Profiling of Osteoporosis and Atherosclerosis in Postmenopausal Women: A Cross-Sectional Study
title Metabolite Profiling of Osteoporosis and Atherosclerosis in Postmenopausal Women: A Cross-Sectional Study
title_full Metabolite Profiling of Osteoporosis and Atherosclerosis in Postmenopausal Women: A Cross-Sectional Study
title_fullStr Metabolite Profiling of Osteoporosis and Atherosclerosis in Postmenopausal Women: A Cross-Sectional Study
title_full_unstemmed Metabolite Profiling of Osteoporosis and Atherosclerosis in Postmenopausal Women: A Cross-Sectional Study
title_short Metabolite Profiling of Osteoporosis and Atherosclerosis in Postmenopausal Women: A Cross-Sectional Study
title_sort metabolite profiling of osteoporosis and atherosclerosis in postmenopausal women: a cross-sectional study
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7719314/
https://www.ncbi.nlm.nih.gov/pubmed/33293818
http://dx.doi.org/10.2147/VHRM.S279028
work_keys_str_mv AT varrimiika metaboliteprofilingofosteoporosisandatherosclerosisinpostmenopausalwomenacrosssectionalstudy
AT niskanenleo metaboliteprofilingofosteoporosisandatherosclerosisinpostmenopausalwomenacrosssectionalstudy
AT tuomainentomipekka metaboliteprofilingofosteoporosisandatherosclerosisinpostmenopausalwomenacrosssectionalstudy
AT honkanenristo metaboliteprofilingofosteoporosisandatherosclerosisinpostmenopausalwomenacrosssectionalstudy
AT krogerheikki metaboliteprofilingofosteoporosisandatherosclerosisinpostmenopausalwomenacrosssectionalstudy
AT tuppurainenmarjot metaboliteprofilingofosteoporosisandatherosclerosisinpostmenopausalwomenacrosssectionalstudy